Home / Publications / Methylglyoxal modification hinders amyloid conversion of prion protein

Methylglyoxal modification hinders amyloid conversion of prion protein

4
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Kudryavtseva S. S. et al. Methylglyoxal modification hinders amyloid conversion of prion protein // Mendeleev Communications. 2018. Vol. 28. No. 3. pp. 314-316.
GOST all authors (up to 50) Copy
Kudryavtseva S. S., Melnikova A. K., Muronetz V. I., Stroylova Y. Y. Methylglyoxal modification hinders amyloid conversion of prion protein // Mendeleev Communications. 2018. Vol. 28. No. 3. pp. 314-316.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2018.05.029
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.05.029
TI - Methylglyoxal modification hinders amyloid conversion of prion protein
T2 - Mendeleev Communications
AU - Kudryavtseva, Sofia Stanislavovna
AU - Melnikova, Aleksandra Kirillovna
AU - Muronetz, Vladimir Izrailevich
AU - Stroylova, Yulia Yur'evna
PY - 2018
DA - 2018/04/27
PB - Mendeleev Communications
SP - 314-316
IS - 3
VL - 28
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Kudryavtseva,
author = {Sofia Stanislavovna Kudryavtseva and Aleksandra Kirillovna Melnikova and Vladimir Izrailevich Muronetz and Yulia Yur'evna Stroylova},
title = {Methylglyoxal modification hinders amyloid conversion of prion protein},
journal = {Mendeleev Communications},
year = {2018},
volume = {28},
publisher = {Mendeleev Communications},
month = {Apr},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.05.029},
number = {3},
pages = {314--316},
doi = {10.1016/j.mencom.2018.05.029}
}
MLA
Cite this
MLA Copy
Kudryavtseva, Sofia Stanislavovna, et al. “Methylglyoxal modification hinders amyloid conversion of prion protein.” Mendeleev Communications, vol. 28, no. 3, Apr. 2018, pp. 314-316. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.05.029.

Abstract

Effect of glycation by methylglyoxal on prion protein (PrP) structure and properties was evaluated. Modification of arginine at 27-position into a hydroimidazolone derivative was confirmed by MALDI-TOF mass spectrometry; circular dichroism spectra and tryptophan fluorescence showed some structural changes, while the hydrodynamic diameter of PrP was not affected by glycation. Glycated PrP formed large amorphous aggregates instead of intermediate oligomers; seeding of glycated PrP by mature fibrils led to a decreased formation of amyloid structures.

References

1.
Glycation, glycolysis, and neurodegenerative diseases: Is there any connection?
Muronetz V.I., Melnikova A.K., Seferbekova Z.N., Barinova K.V., Schmalhausen E.V.
Biochemistry (Moscow), 2017
2.
Glycation in Parkinson's disease and Alzheimer's disease
Vicente Miranda H., El-Agnaf O.M., Outeiro T.F.
Movement Disorders, 2016
4.
Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention
Brings S., Fleming T., Freichel M., Muckenthaler M., Herzig S., Nawroth P.
International Journal of Molecular Sciences, 2017
6.
Glyceraldehyde-3-phosphate dehydrogenase: Aggregation mechanisms and impact on amyloid neurodegenerative diseases
Muronetz V.I., Barinova K.V., Stroylova Y.Y., Semenyuk P.I., Schmalhausen E.V.
International Journal of Biological Macromolecules, 2017
9.
Role of advanced glycation end products in cellular signaling
Ott C., Jacobs K., Haucke E., Navarrete Santos A., Grune T., Simm A.
Redox Biology, 2014
14.
Amyloidogenic Unfolding Intermediates Differentiate Sheep Prion Protein Variants
Rezaei H., Choiset Y., Eghiaian F., Treguer E., Mentre P., Debey P., Grosclaude J., Haertle T.
Journal of Molecular Biology, 2002
15.
Tishina S.A., Stroylov V.S., Zanyatkin I.A., Melnikova A.K., Muronetz V.I., Stroylova Y.Y.
Mendeleev Communications, 2017
16.
Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
Wilham J.M., Orrú C.D., Bessen R.A., Atarashi R., Sano K., Race B., Meade-White K.D., Taubner L.M., Timmes A., Caughey B.
PLoS Pathogens, 2010
17.
Methods for Conversion of Prion Protein into Amyloid Fibrils
Breydo L., Makarava N., Baskakov I.V.
Methods in Molecular Biology, 2008
18.
Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?
Münch G., Lüth H.J., Wong A., Arendt T., Hirsch E., Ravid R., Riederer P.
Journal of Chemical Neuroanatomy, 2000